Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 1/20 | 0.71 |
| ▸ | LMNA | P02545 | 3/20 | 0.71 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.67 |
| ▸ | POLB | P06746 | 2/20 | 0.67 |
| ▸ | ATM | Q13315 | 1/20 | 0.67 |
| ▸ | HSD17B10 | Q99714 | 6/20 | 0.64 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.64 |
| ▸ | TSHR | P16473 | 5/20 | 0.63 |
| ▸ | GAA | P10253 | 2/20 | 0.63 |
| ▸ | MAPT | P10636 | 2/20 | 0.63 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.63 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.62 |
| ▸ | HPGD | P15428 | 3/20 | 0.61 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.61 |
| ▸ | HTT | P42858 | 1/20 | 0.61 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.61 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.59 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.59 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.59 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29655205 | 1.00 | KMT2A (0.71) | KMT2ALMNAKDM4EPOLBATM | |
| SCHEMBL15114720 | 0.87 | KDM4E (0.66) | KMT2ALMNAKDM4EPOLBATM | |
| SCHEMBL13936399 | 0.86 | KMT2A (0.73) | KMT2ALMNAKDM4EPOLBATM | |
| SCHEMBL28600269 | 0.85 | KDM4E (0.62) | KMT2ALMNAKDM4EPOLBATM | |
| SCHEMBL5442803 | 0.85 | KMT2A (0.71) | KMT2ALMNAKDM4EPOLBATM | |
| SCHEMBL10165944 | 0.85 | KMT2A (0.71) | KMT2ALMNAKDM4EPOLBATM | |
| SCHEMBL4341926 | 0.85 | KMT2A (0.71) | KMT2ALMNAKDM4EPOLBATM | |
| SCHEMBL12811737 | 0.85 | KMT2A (0.71) | KMT2ALMNAKDM4EPOLBATM | |
| SCHEMBL18737813 | 0.84 | SMN1; SMN2 (0.63) | KMT2ALMNAKDM4EPOLBATM | |
| SCHEMBL7426825 | 0.84 | HSD17B10 (0.63) | KMT2ALMNAKDM4EPOLBATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 200 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250302678-A1 | ABSORBENT ARTICLES INCLUDING PERFUME AND CYCLODEXTRINS | PROCTER & GAMBLE (US) | 2025-10-02 | — | — | US | claimed |
| US-12350136-B2 | Absorbent articles including perfume and cyclodextrins | THE PROCTER & GAMBLE COMPANY (US) | 2025-07-08 | — | — | US | claimed |
| WO-2024182515-A1 | AGENTS FOR REPELLING, KNOCKING DOWN, AND/OR KILLING BLOOD-SUCKING ARTHROPODS AND USES THEREOF | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF AGRICULTURE (US) | 2024-09-06 | — | — | WO | claimed |
| US-20240292836-A1 | AGENTS FOR REPELLING, KNOCKING DOWN, AND/OR KILLING BLOOD-SUCKING ARTHROPODS AND USES THEREOF | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF AGRICULTURE | 2024-09-05 | — | — | US | claimed |
| WO-2023205458-A2 | FORMULATIONS FOR REPELLING BEES AND OTHER INSECTS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2023-10-26 | — | — | WO | claimed |
| EP-4257663-A1 | FOOD CONTACT SURFACE SANITIZING LIQUID | The Procter & Gamble Company (US) | 2023-10-11 | — | — | EP | claimed |
| US-20220401275-A1 | ABSORBENT ARTICLES INCLUDING PERFUME AND CYCLODEXTRINS | PROCTER & GAMBLE (US) | 2022-12-22 | — | — | US | claimed |
| US-11458049-B2 | Absorbent articles including perfume and cyclodextrins | THE PROCTER & GAMBLE COMPANY (US) | 2022-10-04 | — | — | US | claimed |
| EP-3746532-B1 | COMPOUNDS FOR PROVIDING A LONG-LASTING STRAWBERRY ODOR | FIRMENICH & CIE (CH) | 2022-02-23 | — | — | EP | claimed |
| US-20210363461-A1 | COMPOUNDS FOR PROVIDING A LONG-LASTING STRAWBERRY ODOR | FIRMENICH SA (CH) | 2021-11-25 | — | — | US | claimed |
| EP-3509647-A1 | ABSORBENT ARTICLES INCLUDING PERFUME AND CYCLODEXTRINS | The Procter and Gamble Company (US) | 2019-07-17 | — | — | EP | claimed |
| WO-2018145219-A1 | PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING ADDICTIONS BY MEANS OF AVERSIVE COUNTERCONDITIONING | SERANI MOSTAZAL JORGE (CL) | 2018-08-16 | — | — | WO | claimed |
| WO-2018048852-A1 | ABSORBENT ARTICLES INCLUDING PERFUME AND CYCLODEXTRINS | THE PROCTER & GAMBLE COMPANY (US) | 2018-03-15 | — | — | WO | claimed |
| US-20180064588-A1 | Absorbent Articles Including Perfume and Cyclodextrins | THE PROCTER & GAMBLE COMPANY | 2018-03-08 | — | — | US | claimed |
| CN-100430461-C | Bleaching composition | UNILEVER PLC (NL) | 2008-11-05 | — | — | CN | claimed |
| EP-1668106-B1 | BLEACHING COMPOSITION | UNILEVER PLC (GB) | 2007-04-25 | — | — | EP | claimed |
| US-20070004614-A1 | Bleaching composition | CONOPCO, INC., D/B/A UNILEVER | 2007-01-04 | — | — | US | claimed |
| CN-1863898-A | Bleaching composition | UNILEVER PLC (NL) | 2006-11-15 | — | — | CN | claimed |
| EP-1668106-A1 | BLEACHING COMPOSITION | Unilever Plc (GB) | 2006-06-14 | — | — | EP | claimed |
| WO-2005033256-A1 | BLEACHING COMPOSITION | UNILEVER PLC (GB) | 2005-04-14 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240292836-A1 | AGENTS FOR REPELLING, KNOCKING DOWN, AND/OR KILLING BLOOD-SUCKING ARTHROPODS AND USES THEREOF | L3MBTL4, L3MBTL3, L3MBTL1 | KMT2A 404/4885LMNA 2740/4885KDM4E 276/4885 |
| US-20210363461-A1 | COMPOUNDS FOR PROVIDING A LONG-LASTING STRAWBERRY ODOR | CUTA, TRPA1, COXFA4L2 | KMT2A 3029/4885LMNA 2713/4885KDM4E 1564/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.